Design Therapeutics, Inc.
Design Therapeutics, Inc. (DSGN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dsgn · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$21.00
Consensus
$20.50
+93.9% upside
Low
$20.00
Median: $20.5 · Last Close: $10.57
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$20.50
93.9% upside
High Target
$21
98.7%
Low Target
$20
89.2%
Current Price
$10.57
as of today
Based on analyst price targets, the DSGN stock price prediction for the next 12 months ranges from $20 to $21. The consensus DSGN price forecast of $20.50 implies 93.9% upside from the current price of $10.57.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.04 | ↓ 5.00% |
1-day model range: $9.9–$10.18. Peak: $10.18 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $19 | +81.1% |
| 2028 | $28 | +161.9% |
| 2029 | $34 | +226.1% |
| 2030 | $39 | +270.1% |
| 2031 | — | +297.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DSGN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-10 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-12-03 | Leerink Partners | Upgrade ↑ | Market Perform→Outperform |
| 2025-11-20 | RBC Capital | Upgrade ↑ | Sector Perform→Outperform |
| 2025-11-06 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-08-06 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-05-07 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2024-03-20 | Wedbush | Maintains | Neutral→Neutral |
| 2024-03-20 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2023-11-14 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Design Therapeutics, Inc. (DSGN) stock. Of the recent 28 rating actions, 4 were upgrades and 3 were downgrades. 7 analysts currently cover DSGN.
Analyst Recommendation Trends
DSGN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$117M
↑ 1296.8% YoY
Revenue Next Year
$205M
↑ 74.5% YoY
EPS This Year
$-1.36
EPS Next Year
$-1.64
↑ 20.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast DSGN EPS of $-1.36 for the current fiscal year, based on estimates from 5 analysts. The DSGN revenue forecast is $117M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DSGN stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DSGN price target is $20.50 (+93.9% upside), with an analyst consensus of Buy.
The DSGN short-term stock prediction for tomorrow is $10.04 (-5.00%). The DSGN stock price prediction for 2027 estimates an average of $19. The DSGN stock prediction for 2030 projects a range of $33–$45.
Design Therapeutics, Inc. trades on NASDAQ under the ticker DSGN. The DSGN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
DSGN forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month DSGN price target is $20.50, with a high forecast of $21.00 and a low of $20.00. The median price target is shown in the chart above when available. This implies +93.9% potential upside from the current price of $10.57.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.